Add-On Lipid Drugs for ASCVD After Statins, by Guideline
LDL-C still high on statins or ezetimibe? Compare add-on lipid-lowering drug options and where each fits current ACC/AHA secondary prevention guidance.
7 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 7 of 7 clinical reviews.
LDL-C still high on statins or ezetimibe? Compare add-on lipid-lowering drug options and where each fits current ACC/AHA secondary prevention guidance.
Depression, anxiety, and PTSD occur at 2-3x the general population rate in patients with established cardiovascular disease. Evidence-based screening and treatment reduce both psychiatric burden and recurrent MACE.
A side-by-side comparison of ADA, AACE, Endocrine Society, and ACC/AHA guidance for managing established cardiovascular disease, including GLP-1 receptor agonist therapy, lipid targets, and blood pressure goals, with notes on where the evidence is strong and where it is still evolving.
A guide to the most common conditions that co-occur with established cardiovascular disease, how they interact, and what the evidence says about managing them together.
Evidence-based exercise protocols for patients with established cardiovascular disease, including post-MI, stroke, PAD, and coronary artery disease. Covers cardiac rehab phases, intensity targets, and safety monitoring.
How inherited risk shapes outcomes in patients with established cardiovascular disease, from polygenic risk scores to familial hypercholesterolemia screening and targeted pharmacotherapy.
Evidence-based nutrition and lifestyle protocols for adults with established cardiovascular disease, including post-MI, stroke, PAD, and symptomatic CAD. Covers dietary patterns, physical activity targets, weight management, and GLP-1 therapy based on current AHA, ADA, and ACC guidelines.